PFE
23
7
GT
62
6
CMA
61
5
NEE
50
-5
EQIX
64
2
EFX
38
2
TSCO
49
5
RHI
59
2
NWS
66
-3
SNA
68
-2
MCD
52
2
AIV
72
2
XRX
44
3
AA
48
-12
VZ
50
3
CL
58
2
PNC
64
4
CCI
31
3
LMT
34
2
EMN
60
4
PFE
23
7
GT
62
6
CMA
61
5
NEE
50
-5
EQIX
64
2
EFX
38
2
TSCO
49
5
RHI
59
2
NWS
66
-3
SNA
68
-2
MCD
52
2
AIV
72
2
XRX
44
3
AA
48
-12
VZ
50
3
CL
58
2
PNC
64
4
CCI
31
3
LMT
34
2
EMN
60
4
Financhill
Back

Edap TMS SA 10K Form

Sell
23

EDAP
Edap TMS SA

Last Price:
2.47
Seasonality Move:
25.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EDAP News And Ratings

See the #1 stock for the next 7 days that we like better than EDAP

EDAP Financial Statistics

Sales & Book Value

Annual Sales: $65.41M
Cash Flow: $-6.69M
Price / Cash Flow: 0
Annual Sales: $1.28
Price / Book: 1.92

Profitability

EPS (TTM): -0.62960
Net Income (TTM): $-24.01M
Gross Margin: $26.43M
Return on Equity: -42.5%
Return on Assets: -25.41%

Edap TMS SA Earnings Forecast

Key Edap TMS SA Financial Ratios

  • The Gross Profit Margin over the past 27 years for EDAP is 40.40%.
  • The Selling, General & Administrative Expenses for EDAP have been equal to 61.67% of Gross Profit Margin.
  • The Research & Development expenses have been 11.52% of Revenue.
  • The Interest Expense is -1.10% of Operating Income.
  • The Net Earning history of EDAP is -35.05% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 12 years.

Edap TMS SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: EDAP
CUSIP: 268311
Website: edap-tms.com

Debt

Debt-to-Equity Ratio: 0.09
Current Ratio: 2.18
Quick Ratio: 1.42

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EDAP Technical Analysis vs Fundamental Analysis

Sell
23
Edap TMS SA (EDAP) is a Sell

Is Edap TMS SA a Buy or a Sell?

  • Edap TMS SA stock is rated a Sell
    The current Edap TMS SA [EDAP] share price is $2.47. The Score for EDAP is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.